Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mannitol revisited

M Davis1, M Lucatorto

  • 1Neuroscience Intensive Care Unit at Shadyside Hospital, Pittsburgh, Pennsylvania 15232.

The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LOH and mutation analysis of CDKN2 in primary human ovarian cancers.

International journal of cancer·1995
Same author

Peptidyl alpha-ketoheterocyclic inhibitors of human neutrophil elastase. 3. In vitro and in vivo potency of a series of peptidyl alpha-ketobenzoxazoles.

Journal of medicinal chemistry·1995
Same author

Myositis and fasciitis associated with group A beta hemolytic streptococcal infections: development of a rabbit model.

The Journal of laboratory and clinical medicine·1995
Same author

Esophago-airway fistula in AIDS.

The Annals of thoracic surgery·1995
Same author

Lesions of the central nucleus of the amygdala block conditioned excitation, but not conditioned inhibition of fear as measured with the fear-potentiated startle effect.

Behavioral neuroscience·1995
Same author

Habituation of prepulse inhibition of the startle reflex using an auditory prepulse close to background noise.

Behavioral neuroscience·1995

Osmotic therapy using mannitol effectively reduces intracranial pressure (ICP). While its exact mechanisms are still being explored, careful nursing monitoring is crucial to manage potential complications.

Area of Science:

  • Neurology
  • Neurosurgery
  • Critical Care Medicine

Background:

  • Osmotic therapy has been investigated for intracranial pressure (ICP) reduction since 1919.
  • Mannitol is the primary osmotic agent currently employed for ICP management.
  • The efficacy of mannitol in lowering ICP is well-established, though its precise mechanisms require further elucidation.

Purpose of the Study:

  • To review the mechanisms by which mannitol reduces ICP.
  • To outline potential benefits of mannitol beyond ICP reduction, such as improved cerebral perfusion and neuroprotection.
  • To detail common complications and essential nursing considerations for patients receiving mannitol therapy.

Main Methods:

  • Review of existing literature on osmotic therapy and mannitol.

Related Experiment Videos

  • Analysis of proposed mechanisms of action for mannitol in reducing ICP.
  • Identification and summary of reported complications and nursing care strategies.

    • Main Results:

    • Mannitol is believed to reduce ICP by decreasing brain and cerebrospinal fluid (CSF) volume and reducing blood volume via vasoconstriction.
    • Potential benefits include improved cerebral perfusion through altered blood viscosity and red blood cell rheology, and possible protection against biochemical injury.
    • Common adverse effects include fluid/electrolyte imbalances, cardiopulmonary edema, and rebound cerebral edema.

    Conclusions:

    • Mannitol is an effective osmotic agent for ICP reduction, acting through multiple potential pathways.
    • Understanding these mechanisms and potential complications is vital for optimizing patient outcomes.
    • Vigilant nursing assessment and management are critical for patients undergoing osmotic therapy with mannitol.